EBRO 2017

IASLC Lung Cancer Staging Project RPA on 12 428 NSCLC treated 1990-2000 weight loss, comorbidities not included Group Stage PS Age Survival (med) I IA-IIA any any 53 months II IIB-IIIA 0-1 any 16 months

IIB-IIIA IIIB-IV IIIB-IV IIB-IIIA IIIB-IV IIIB-IV

2 0 1

any any <81 any any >80

III

8 months

3-4 2-4 1

IV

3 months

Sculier J Thorac Oncol 2008